INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Aurobindo Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 524804	ISIN Demat INE406A01037	Book Value 369.16	NSE Symbol AUROPHARMA	Dividend Yield (%) 0	Market Cap (₹ Cr.) 69,330.29	P/E 34.31	EPS 34.79	Face Value 1

Particulars (₹ Cr)	Mar2025	Mar2024	Mar2023	Mar2022	Mar2021
Revenue From Operations	10,933.30	10,645.64	12,792.28	11,287.14	15,823.68
Sale of Products	10,586.11	10,270.85	12,406.36	11,059.49	15,610.73
Sale of Services	201.98	271.36	201.18	190.58	11.45
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	145.21	103.43	184.74	37.07	201.50
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	10,933.30	10,645.64	12,792.28	11,287.14	15,823.68
Other Income	328.12	616.06	433.76	670.99	589.86
Total Revenue	11,261.42	11,261.70	13,226.04	11,958.13	16,413.54
Changes in Inventories	-67.66	-116.23	-466.00	45.51	2.99
Cost of Material Consumed	5,610.21	5,761.08	7,247.69	5,783.93	7,215.74
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	65.13	203.40	89.23	16.81	26.09
Employee Benefits	1,063.07	980.56	1,641.88	1,600.04	1,735.42
Total Other Expenses	1,704.98	1,592.79	2,548.56	2,367.45	2,723.61
Manufacturing / Operating Expenses	612.22	606.09	1,264.83	1,183.67	1,438.20
Administrative and Selling Expenses	960.27	822.21	1,089.33	1,009.36	1,069.84
Other Expenses	132.49	164.49	194.40	174.42	215.57
Finance Costs	230.04	182.60	114.98	16.94	28.68
Depreciation and Amortization	297.20	254.58	435.35	415.26	488.00
Total Expenses	8,902.97	8,858.78	11,611.69	10,245.94	12,220.53
Profit Before Exceptional Items and Tax	2,358.45	2,402.92	1,614.35	1,712.19	4,193.01
Exceptional Items Before Tax	0.00	0.00	0.00	-74.71	0.00
Profit Before Extraordinary Items and Tax	2,358.45	2,402.92	1,614.35	1,637.48	4,193.01
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	2,358.45	2,402.92	1,614.35	1,637.48	4,193.01
Taxation	611.66	502.82	383.94	182.77	1,080.10
Current Tax	627.37	598.08	407.02	379.70	1,043.34
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-15.71	-95.26	-23.08	-196.93	36.76
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	1,746.79	1,900.10	1,230.41	1,454.71	3,112.91
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	54.04	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	72.49	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	-18.45	0.00	0.00	0.00
Profit Attributable to Shareholders	1,746.79	1,954.14	1,230.41	1,454.71	3,112.91
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	1,746.79	1,954.14	1,230.41	1,454.71	3,112.91
Earning Per Share - Basic	29.97	33.35	21.00	24.83	53.13
Earning Per Share - Diluted	29.97	33.35	21.00	24.83	53.13
Operation Profit before Depreciation	2,885.69	2,840.10	2,164.68	2,144.39	4,709.69
Operating Profit after Depreciation	2,588.49	2,585.52	1,729.33	1,729.13	4,221.69
Dividend Per Share	0.00	4.50	7.50	9.00	4.00
Dividend Percentage	0.00	450.00	750.00	900.00	400.00
Equity Dividend	0.00	263.66	439.45	527.32	234.37
Weighted Average Shares - Basic	58.29	58.59	58.59	58.59	58.59
Weighted Average Shares - Diluted	58.29	58.59	58.59	58.59	58.59